跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Abingem - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Abingem
Approved
STANDARD
Abingem
Naprod Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9d095a2fb418691c
Company
Naprod Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
9d095a2fb418691c
Drug Approval Philippines Name
Abingem
Product Name
Abingem
Registration Number
DR-XY35601
Brand Name
Abingem
Generic Name
Gemcitabine(As Hydrochloride)
Dosage Form
Lyophilized Powder for Injection (IV)
Dosage Strength
1 gram
Manufacturer
Naprod Lifesciences Pvt. Ltd.
Importer
Multicare Pharmaceuticals Phils. Inc.
Distributor
Multicare Pharmaceuticals Phils. Inc.
Issuance Date
29 December 2020
Expiry Date
12 January 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9d095a2fb418691c
Type
Standard
Back to Philippines FDA Approvals